Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,036 | 538 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,318 | 173 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $733.33 | 20 | $0 (2024) |
| Novo Nordisk Inc | $613.55 | 54 | $0 (2024) |
| Lilly USA, LLC | $527.85 | 44 | $0 (2024) |
| Lundbeck LLC | $453.75 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $261.79 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $261.29 | 21 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $250.73 | 23 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $247.59 | 27 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $190.95 | 20 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,333 | 201 | ABBVIE INC. ($799.11) |
| 2023 | $2,476 | 162 | ABBVIE INC. ($826.55) |
| 2022 | $1,374 | 103 | ABBVIE INC. ($370.97) |
| 2021 | $852.19 | 72 | AbbVie Inc. ($321.79) |
All Payment Transactions
538 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.15 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: UROLOGY | ||||||
| 12/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Biological | ||||||
| 12/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/26/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $10.30 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Obesity | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 320 | 468 | $48,053 | $21,544 |
| 2022 | 2 | 308 | 450 | $44,309 | $18,740 |
| 2021 | 2 | 324 | 507 | $48,435 | $23,180 |
| 2020 | 2 | 327 | 499 | $45,760 | $16,935 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 187 | 287 | $28,987 | $13,793 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 111 | 154 | $14,476 | $5,786 | 40.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 22 | 27 | $4,590 | $1,965 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 182 | 287 | $28,987 | $13,069 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 126 | 163 | $15,322 | $5,671 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 168 | 282 | $29,589 | $14,259 | 48.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 156 | 225 | $18,846 | $8,921 | 47.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 174 | 285 | $30,780 | $11,035 | 35.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 153 | 214 | $14,980 | $5,900 | 39.4% |
About Amber Campbell, CNP
Amber Campbell, CNP is a Family healthcare provider based in Ontario, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2016. The National Provider Identifier (NPI) number assigned to this provider is 1891247441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amber Campbell, CNP has received a total of $8,036 in payments from pharmaceutical and medical device companies, with $3,333 received in 2024. These payments were reported across 538 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,036).
As a Medicare-enrolled provider, Campbell has provided services to 1,279 Medicare beneficiaries, totaling 1,924 services with total Medicare billing of $80,399. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Ontario, OH
- Active Since 10/31/2016
- Last Updated 12/28/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1891247441
Products in Payments
- UBRELVY (Drug) $856.43
- VRAYLAR (Drug) $537.49
- NURTEC ODT (Drug) $489.97
- REXULTI (Drug) $455.75
- QULIPTA (Drug) $378.49
- JARDIANCE (Drug) $281.58
- FARXIGA (Drug) $280.45
- Wegovy (Drug) $261.09
- Kerendia (Drug) $250.73
- SPRAVATO (Drug) $250.22
- BREZTRI (Drug) $237.37
- MOUNJARO (Drug) $226.64
- LINZESS (Drug) $224.82
- TRELEGY ELLIPTA (Drug) $216.71
- VIBERZI (Drug) $214.02
- Rybelsus (Drug) $204.85
- AIRSUPRA (Drug) $201.62
- VYEPTI (Biological) $170.05
- Cologuard Collection Kit (Device) $133.88
- FANAPT (Drug) $131.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ontario
Natalie Roby, N.p, N.P
Family — Payments: $5,161
Patty Fleming, Cnp, CNP
Family — Payments: $4,259
Mrs. Julie Burkhart, Aprn, Np-C, APRN, NP-C
Family — Payments: $3,466
Kiersten Hogg, Dnp, Fnp, DNP, FNP
Family — Payments: $2,728
Mr. Michael Conley, Np, NP
Family — Payments: $2,477
Martha Ruiz, Fnp, FNP
Family — Payments: $1,843